Literature DB >> 7426273

Drug metabolism and liver function after methyldopa withdrawal.

A Ylikallio, E A Sotaniemi.   

Abstract

1 The effects of methyldopa withdrawal on liver function and drug metabolism were investigated in ten elderly females suffering from the drug-induced orthostatic reaction and resistant hypertension. 2 There was a significant increase in serum albumin level, antipyrine metabolism and urinary excretion of D-glucaric acid 6 months after the methyldopa withdrawal. 3 The results suggest that patients treated with methyldopa might show a reduced metabolizing ability in spite of normal liver function tests.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426273      PMCID: PMC1430037          DOI: 10.1111/j.1365-2125.1980.tb01727.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  CHANGES IN ENZYME ACTIVITY, RELATED TO D-GLUCARIC ACID SYNTHESIS, WITH AGE, PREGNANCY AND MALIGNANCY.

Authors:  C A MARSH; A J CARR
Journal:  Clin Sci       Date:  1965-04       Impact factor: 6.124

2.  Histological changes in the liver and indices of drug metabolism in alcoholics.

Authors:  E A Sotaniemi; J Ahlqvist; R O Pelkonen; H Pirttiaho; P V Luoma
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

3.  Rapid gas-liquid chromatographic estimation of antipyrine in plasma.

Authors:  L F Prescott; K K Adjepon-Yamoah; E Roberts
Journal:  J Pharm Pharmacol       Date:  1973-03       Impact factor: 3.765

4.  Glucaric acid as an indicator of use of enzyme-inducing drugs.

Authors:  E A Sotaniemi; F Medzihradsky; G Eliasson
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

5.  Classification of smooth muscle autoantibodies detected by immunofluorescence.

Authors:  G F Bottazzo; A Florin-Christensen; A Fairfax; G Swana; D Doniach; U Groeschel-Stewart
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

6.  Effects of caloric and noncaloric materials in fasting hyperbilirubinemia.

Authors:  P V Barrett
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

7.  Hepatic injury and drug metabolism in patients with alpha-methyldopa-induced liver damage.

Authors:  E A Sotaniemi; O T Hokkanen; J T Ahokas; R O Pelkonen; J Ahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

8.  Methyldopa liver damage.

Authors:  P J Toghill; P G Smith; P Benton; R C Brown; H L Matthews
Journal:  Br Med J       Date:  1974-08-31

9.  Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.

Authors:  E Dybing; S D Nelson; J R Mitchell; H A Sasame; J R Gillette
Journal:  Mol Pharmacol       Date:  1976-11       Impact factor: 4.436

10.  Effect of age and sex on human drug metabolism.

Authors:  K O'Malley; J Crooks; E Duke; I H Stevenson
Journal:  Br Med J       Date:  1971-09-11
  10 in total
  1 in total

1.  Antibody mediated hepatocyte injury in methyl dopa induced hepatotoxicity.

Authors:  J Neuberger; J G Kenna; K Nouri Aria; R Williams
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.